SCHEMBL20048255

SCHEMBL20048255

CC(C)N(C)c1ccc(C2CC3(C)C(O)CCC3C3CCC4=CC(=O)CCC4C23)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 10/20 0.62
▸ NR3C1 P04150 10/20 0.62
▸ AR P10275 9/20 0.62
▸ CYP3A4 P08684 1/20 0.62
▸ SERPINA6 P08185 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ SLC22A1 O15245 1/20 0.54
▸ SHBG P04278 1/20 0.54
▸ THRB P10828 1/20 0.54
▸ HSD17B10 Q99714 2/20 0.41
▸ MCL1 Q07820 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ PDK1 Q15118 1/20 0.39
▸ PDK2 Q15119 1/20 0.39
▸ PDK3 Q15120 1/20 0.39
▸ PDK4 Q16654 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21470226 1.00 PGR (0.62) PGRNR3C1ARCYP3A4SERPINA6
SCHEMBL23131152 1.00 PGR (0.62) PGRNR3C1ARCYP3A4SERPINA6
SCHEMBL18306390 0.91 PGR (0.60) PGRNR3C1ARCYP3A4SERPINA6
SCHEMBL19032618 0.91 PGR (0.60) PGRNR3C1ARCYP3A4SERPINA6
SCHEMBL1591672 0.91 PGR (0.60) PGRNR3C1ARCYP3A4SERPINA6
SCHEMBL19042720 0.91 PGR (0.60) PGRNR3C1ARCYP3A4SERPINA6
SCHEMBL20048359 0.88 PGR (0.60) PGRNR3C1ARCYP3A4SERPINA6
SCHEMBL23131108 0.88 PGR (0.60) PGRNR3C1ARCYP3A4SERPINA6
SCHEMBL23131127 0.87 PGR (0.53) PGRNR3C1ARCYP3A4SERPINA6
SCHEMBL23131151 0.87 PGR (0.55) PGRNR3C1ARCYP3A4SERPINA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022192182-A2 USES OF GLUCOCORTICOID RECEPTOR (GR) ANTAGONIST, ANTIANDROGEN, AND AKT INHIBITOR/PI3K INHIBITOR/mTOR INHIBITOR COMBINATIONS ORIC PHARMACEUTICALS, INC. (US) 2022-09-15 — — WO disclosed
WO-2021163273-A1 USES OF GLUCOCORTICOID RECEPTOR ANTAGONISTS ORIC PHARMACEUTICALS, INC. (US) 2021-08-19 — — WO disclosed
EP-3851444-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR Oric Pharmaceuticals, Inc. (US) 2021-07-21 — — EP disclosed
EP-3523315-B1 INHIBITOR OF GLUCOCORTICOID RECEPTOR ORIC PHARMACEUTICALS INC (US) 2021-03-24 — — EP disclosed
WO-2019200156-A1 SOLID FORMS AND FORMULATIONS COMPRISING A GLUCOCORTICOID RECEPTOR ANTAGONIST AND USES THEREOF ORIC PHARMACEUTICALS, INC. (US) 2019-10-17 — — WO disclosed
WO-2018068021-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR ORIC PHARMACEUTICALS, INC. (US) 2018-04-12 — — WO disclosed
Send feedback